Acadia Pharmaceuticals Inc
ACAD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001070494
In the last 90 days, Acadia Pharmaceuticals Inc insiders filed 0 open-market purchases and 2 sales; 353 institutions reported holding it in 13F filings for Q2 2026, worth $4.27B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Acadia Pharmaceuticals Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 2 filings
- 2 insiders, $1.02M in total
- Insiders trading
- 2
- Net value
- −$1.02M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Acadia Pharmaceuticals Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 67,828 | Aug 7, 2026 | 6 |
| Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | 18,994 | Jul 31, 2026 | 3 |
| Kihara James | PRINCIPAL ACCOUNTING OFFICER | 13,088 | Jun 29, 2026 | 7 |
| Baker Julian | Director, 10% Owner | 39,384,587Indirect | Jun 2, 2026 | 1 |
| Baker Felix | Director, 10% Owner | 39,384,587Indirect | Jun 2, 2026 | 1 |
| Baker Bros. Advisors LP | Director, 10% Owner | 39,384,587Indirect | Jun 2, 2026 | 1 |
| Baker Brothers Life Sciences LP | Director, 10% Owner | 39,384,587Indirect | Jun 2, 2026 | 1 |
| 667, L.P. | Director, 10% Owner | 39,384,587Indirect | Jun 2, 2026 | 1 |
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | 39,384,587Indirect | Jun 2, 2026 | 1 |
| Harrigan Edmund | Director | 43,148 | Jun 1, 2026 | 1 |
| Brege Laura | Director | 23,202 | Jun 1, 2026 | 1 |
| Daly James M | Director | 12,148 | Jun 1, 2026 | 2 |
| Poole Jonathan | Director | 2,010 | Jun 1, 2026 | 2 |
| Garofalo Elizabeth A. | Director | 33,489 | Jun 1, 2026 | 1 |
| Ndu Adora | Director | 32,908 | Jun 1, 2026 | 1 |
| Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | 11,280 | Mar 26, 2026 | 3 |
| Owen Catherine E. | Chief Executive Officer | 14,803 | Mar 26, 2026 | 2 |
| Garner Thomas | EVP, Chief Commercial Officer | – | Mar 10, 2026 | 1 |
| Soland Daniel B | Director | 44,041 | Jun 2, 2025 | 0 |
| Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | 62,105 | Nov 19, 2024 | 0 |
| Davis Stephen | CEO | 186,555 | Aug 20, 2024 | 0 |
| Kim Austin D. | EVP,General Counsel, Secretary | 46,901 | Jan 9, 2024 | 0 |
| Williamson Douglas J | Executive VP, Research & Dev | – | Feb 13, 2023 | 0 |
| Stankovic Srdjan R. | President | 61,234 | Nov 22, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2026 (view filing) | Feb 9 | 1 day | Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SEC | SSale | −6.95K | $23.38 | −$162.5K | −47.7%7.61K after | |
| Mar 26, 2026 (view filing) | Mar 25 | 1 day | Rhodes Jennifer JEVP, CHIEF LEGAL OFFICER, SEC | SSale | −3.84K | $21.47 | −$82.5K | −25.4%11.3K after | |
| Mar 26, 2026 (view filing) | Mar 25-26 | 1 day | Kihara JamesPRINCIPAL ACCOUNTING OFFICER | SSale | −1.94K | $21.57 | −$41.9K | −6.7%26.9K after | 3 lots |
| Mar 26, 2026 (view filing) | Mar 25 | 1 day | Owen Catherine E.Chief Executive Officer | SSale | −11.6K | $21.47 | −$249.9K | −44.0%14.8K after | |
| Mar 26, 2026 (view filing) | Mar 25 | 1 day | Thompson Elizabeth H.Z.EVP, Head of Research & Dev | SSale | −3.44K | $21.47 | −$73.7K | −51.2%3.28K after | |
| Mar 26, 2026 (view filing) | Mar 25-26 | 1 day | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | SSale | −7.38K | $21.55 | −$159.1K | −10.9%60.3K after | 3 lots |
| Apr 7, 2026 (view filing) | Apr 7 | Same day | Kihara JamesPRINCIPAL ACCOUNTING OFFICER | SSale | −1.03K | $22.20 | −$22.9K | −3.6%27.9K after | |
| Apr 7, 2026 (view filing) | Apr 7 | Same day | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | SSale | −2.71K | $22.20 | −$60.1K | −4.1%62.8K after | |
| May 5, 2026 (view filing) | May 4 | 1 day | Kihara JamesPRINCIPAL ACCOUNTING OFFICER | SSale | −1.33K | $21.79 | −$29.0K | −4.4%29.1K after | |
| May 5, 2026 (view filing) | May 4 | 1 day | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | SSale | −3.51K | $21.79 | −$76.4K | −5.0%66.1K after | |
| May 27, 2026 (view filing) | May 26 | 1 day | Kihara JamesPRINCIPAL ACCOUNTING OFFICER | SSale | −5.40K | $21.18 | −$114.4K | −18.1%24.5K after | |
| Jun 29, 2026 (view filing) | Jun 26 | 3 days | Kihara JamesPRINCIPAL ACCOUNTING OFFICER | SSale | −11.4K | $26.08 | −$297.9K | −46.6%13.1K after | 10b5-1 |
| Jul 31, 2026 (view filing)6:00 PM ET | Jul 30 | 1 day | Thompson Elizabeth H.Z.EVP, Head of Research & Dev | SSale | −16.6K | $26.13 | −$432.7K | −46.6%19.0K after | 2 lots |
| Aug 7, 2026 (view filing)6:00 PM ET | Aug 5-6 | 2 days | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | SSale | −20.1K | $29.16 | −$587.2K | −22.9%67.8K after | 3 lots10b5-1 |